Romi Gupta
16PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Dec 09, 2025
Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression.Suresh Chava, Suresh Bugide, Parmanand Malvi
|Dec 02, 2025
ATAD2 drives melanoma growth and progression and inhibits ferroptosis.Ashok Mari, Kevin Graciano, Raj Kumar
|Jun 13, 2025
Exploring the therapeutic use and outcome of antibody-drug conjugates in ovarian cancer treatment.Revu V L Narayana, Romi Gupta
|Jul 09, 2024
IκBα kinase inhibitor BAY 11-7082 promotes anti-tumor effect in RAS-driven cancers.Praveen Guruvaiah, Romi Gupta
|Jun 26, 2024
ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability.Kiran Kumar Reddi, Suresh Chava, Siva Chander Chabattula
|Jul 21, 2023
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE.Praveen Guruvaiah, Suresh Chava, Chiao-Wang Sun
Pageof 3
Frequent Collaborators
6 joint publications
Narendra Wajapeyee
3 joint publications
Michael R Green
2 joint publications
Parmanand Malvi
2 joint publications
Radoslav Janostiak
2 joint publications
Suresh Bugide
2 joint publications
Yvonne J K Edwards
2 joint publications
Suresh Chava
1 joint publications
Keshab Raj Parajuli
1 joint publications
Vipin Rawat
1 joint publications
Eddy S Yang
